0
Signin
countryflagUS

18889881171

AAPL 173.18 2.2918% MSFT 397.84 0.7343% GOOG 168.46 1.7455% GOOGL 166.62 1.6844% AMZN 184.72 3.1955% NVDA 858.11 3.3357% META 441.84 0.6034% TSLA 180.1 0.0611% TSM 136.23 0.956% LLY 755.91 -2.683% V 267.61 0.1085% AVGO 1238.3 -0.3669% JPM 191.66 -0.1042% UNH 492.97 1.8302% NVO 124.02 -4.0167% WMT 59.71 1.4613% LVMUY 164.94 0.5609% XOM 116.24 0.181% LVMHF 825.49 0.3843% MA 441.1 -0.2194%

Medibank Private Limited

Financial Services US MDBPF

2.45USD
-(-%)

Last update at 2024-05-01T13:30:00Z

Day Range

2.452.45
LowHigh

52 Week Range

1.652.05
LowHigh

Financials

Income Statement

Balancesheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2023-06-30 2022-06-30 2021-06-30 2020-06-30 2019-06-30
Type yearly yearly yearly yearly yearly
Date 2023-06-30 2022-06-30 2021-06-30 2020-06-30 2019-06-30
Income before tax 727.10M 560.00M 632.30M 450.20M 616.30M
Minority interest - - - - -
Net income 511.10M 393.90M 441.20M 315.00M 458.70M
Selling general administrative 786.50M 752.00M 745.90M 742.90M 719.80M
Selling and marketing expenses - - - - -
Gross profit - - - - -
Reconciled depreciation 118.40M 115.00M 82.70M 88.80M 64.10M
Ebit 730.30M 557.90M 636.10M 453.60M 616.30M
Ebitda - - - - -
Depreciation and amortization - - - - -
Non operating income net other - - - - -
Operating income - - - - -
Other operating expenses - - - - -
Interest expense 1.80M 2.40M 0.00000M 0.00000M 0.00000M
Tax provision 216.00M 166.10M 191.10M 134.60M 178.60M
Interest income 86.00M 17.90M 17.70M 29.70M 47.30M
Net interest income -1.80000M -2.40000M -2.80000M -3.40000M -
Extraordinary items - - - - -
Non recurring - - - - -
Other items - - - - -
Income tax expense 216.00M 166.10M 191.10M 134.60M 178.60M
Total revenue 7499.30M 7092.40M 7011.00M 6778.60M 6752.30M
Total operating expenses 6772.20M 6532.40M 6378.70M 6328.40M 6136.00M
Cost of revenue - - - - -
Total other income expense net 174.30M 248.30M 221.10M 222.30M 191.50M
Discontinued operations - - - -0.60000M 21.00M
Net income from continuing ops 511.10M 393.90M 441.20M 315.60M 437.70M
Net income applicable to common shares 511.10M 393.90M 441.20M 315.00M 458.70M
Preferred stock and other adjustments - - - - -
Breakdown 2023-06-30 2022-06-30 2021-06-30 2020-06-30 2019-06-30
Type yearly yearly yearly yearly yearly
Date 2023-06-30 2022-06-30 2021-06-30 2020-06-30 2019-06-30
Total assets 4388.80M 4552.80M 3923.80M 3763.80M 3630.80M
Intangible assets 123.60M 127.80M 140.80M 181.50M 201.40M
Earning assets - - - - -
Other current assets 42.70M 32.70M 32.00M 44.10M 75.70M
Total liab 2304.40M 2607.20M 2017.70M 1949.90M 1695.40M
Total stockholder equity 2084.40M 1945.60M 1906.10M 1813.90M 1935.40M
Deferred long term liab - - - - -
Other current liab 998.10M 1235.10M 895.20M 821.30M 828.10M
Common stock 85.00M 85.00M 85.00M 85.00M 85.00M
Capital stock 85.00M 85.00M 85.00M 85.00M 85.00M
Retained earnings 1971.50M 1834.90M 1798.80M 1690.40M 1826.00M
Other liab 177.30M 120.50M 97.10M 108.40M 151.70M
Good will 204.50M 204.50M 204.50M 204.50M 204.50M
Other assets 134.30M 249.60M 94.10M 97.60M 0.70M
Cash 420.60M 596.70M 671.70M 871.40M 656.50M
Cash and equivalents - - - - -
Total current liabilities 2102.70M 2440.00M 1855.30M 1760.20M 1517.50M
Current deferred revenue - - - - -
Net debt - - - - -
Short term debt - - - - -
Short long term debt - - - - -
Short long term debt total - - - - -
Other stockholder equity 27.90M 25.70M 22.30M 22.40M 24.40M
Property plant equipment 70.50M 88.40M 101.70M 112.20M 49.30M
Total current assets 3659.20M 3695.90M 3224.50M 3096.10M 3095.30M
Long term investments 392.10M 338.30M 343.80M 298.40M 302.00M
Net tangible assets 1756.30M 1613.30M 1560.80M 1434.10M 1529.50M
Short term investments 274.50M 234.60M 266.70M 298.40M 302.00M
Net receivables 329.10M 212.00M 208.90M 185.90M 232.40M
Long term debt - - - - -
Inventory - - - - -
Accounts payable 983.00M 1102.30M 862.30M 858.50M 639.80M
Total permanent equity - - - - -
Noncontrolling interest in consolidated entity - - - - -
Temporary equity redeemable noncontrolling interests - - - - -
Accumulated other comprehensive income - - - - -
Additional paid in capital - - - - -
Common stock total equity - - - - -
Preferred stock total equity - - - - -
Retained earnings total equity - - - - -
Treasury stock - - - - -
Accumulated amortization - - - - -
Non currrent assets other - - - - -
Deferred long term asset charges - - - - -
Non current assets total - - - - -
Capital lease obligations - - - - -
Long term debt total - - - - -
Breakdown 2023-06-30 2022-06-30 2021-06-30 2020-06-30 2019-06-30
Type yearly yearly yearly yearly yearly
Date 2023-06-30 2022-06-30 2021-06-30 2020-06-30 2019-06-30
Investments 29.20M -602.70000M -284.10000M 110.70M 205.80M
Change to liabilities 99.20M 14.50M 31.30M -157.60000M -2.30000M
Total cashflows from investing activities 58.50M -623.60000M -306.10000M 109.20M 129.10M
Net borrowings -39.70000M -38.80000M -37.00000M -33.30000M -33.30000M
Total cash from financing activities -419.10000M -399.90000M -375.80000M -466.70000M -358.80000M
Change to operating activities -180.50000M 282.80M 71.40M 228.10M -51.90000M
Net income 511.10M 393.90M 441.20M 315.00M 458.70M
Change in cash -176.10000M -75.00000M -199.70000M 214.90M 186.40M
Begin period cash flow 596.70M 671.70M 871.40M 656.50M 470.10M
End period cash flow 420.60M 596.70M 671.70M 871.40M 656.50M
Total cash from operating activities 184.50M 948.50M 482.20M 572.40M 416.10M
Issuance of capital stock - - - - -
Depreciation 40.70M 41.20M 45.10M 49.20M 21.90M
Other cashflows from investing activities 71.20M 14.20M 13.10M 27.80M 42.90M
Dividends paid 374.50M 358.00M 333.20M 360.70M 355.30M
Change to inventory - - - - -
Change to account receivables -22.00000M -11.10000M -8.80000M 9.90M 6.30M
Sale purchase of stock -4.90000M -3.10000M -5.60000M -3.80000M -3.50000M
Other cashflows from financing activities - - - - -
Change to netincome -126.90000M 30.20M -111.00000M 13.80M -72.90000M
Capital expenditures 7.80M 7.00M 10.90M 3.20M 9.80M
Change receivables - - - - -
Cash flows other operating - - - - -
Exchange rate changes - - - - -
Cash and cash equivalents changes - - - - -
Change in working capital - - - - -
Stock based compensation - - - - -
Other non cash items - - - - -
Free cash flow 142.60M 913.40M 447.10M 543.10M 366.60M

Fundamentals

  • Previous Close 2.45
  • Market Cap6569.87M
  • Volume0
  • P/E Ratio12.69
  • Dividend Yield5.73%
  • EBITDA743.40M
  • Revenue TTM7494.90M
  • Revenue Per Share TTM2.72
  • Gross Profit TTM 1635.20M
  • Diluted EPS TTM0.13

Peer Comparison

Sector: Financial Services Industry: Insurance - Specialty

Company Change (USD) Price (USD) Trailing PE (x) Forward PE (x) Price Sales TTM (x) Price to Book Value (x) Enterprise Value to Revenue (x)
MDBPF
Medibank Private Limited		 - -% 2.45 12.69 11.52 0.88 3.23 0.85
FNF
Fidelity National Financial Inc		 0.87 1.74% 51.01 30.23 12.82 1.21 2.14 1.35
RYAN
Ryan Specialty Group Holdings Inc		 0.53 1.01% 52.95 92.15 24.81 5.63 9.12 3.21
AIZ
Assurant Inc		 -0.03 0.02% 174.62 16.96 11.05 0.80 1.96 0.88
FAF
First American Corporation		 0.88 1.65% 54.09 28.12 9.38 1.06 1.47 1.15

Reports Covered

Stock Research & News

View All

Profile

Medibank Private Limited provides private health insurance and health services in Australia. The company operates in two segments, Health Insurance and Medibank Health. The Health Insurance segment provides private health insurance products, including hospital cover that offers members with health cover for hospital treatments; and ancillary cover, which provides members with health cover for healthcare services, such as dental, optical, and physiotherapy. This segment also offers health insurance products to overseas visitors and overseas students. The Medibank Health segment provides health management and in-home care services, as well as a range of telehealth services to government and corporate customers; and distributes travel, life, and pet insurance products. The company underwrites its health insurance products under the Medibank and ahm brands. Medibank Private Limited was founded in 1976 and is based in Docklands, Australia.

Medibank Private Limited

720 Bourke Street, Docklands, VIC, Australia, 3008

Key Executives

Name Title Year Born
Mr. David Koczkar B.Com., BCom, MAICD, PGDipFinance CEO, MD & Director 1973
Mr. Mark Rogers B.Sc., BEng (Hons), BSc Group Exec. of CFO & Group Strategy NA
Dr. Andrew Wilson FACHSE, FRANZCP, M.M., MBBS, MM Group Exec. & CEO of Amplar Health NA
Mr. Milosh Milisavljevic Group Exec. of Customer Portfolios NA
Mr. John Goodall B.Sc., BSc (Hons) Group Exec. of Technology & Operations NA
Mr. Peter Kopanidis Sr. Exec. of Corp. Fin. NA
Colette Campbell Sr. Exec. of Investor Relations NA
Ms. Mei Ramsay B.A., BA, L.L.B., L.L.M., LLB, LLM Group Exec. of Legal, Governance & Compliance and Company Sec. NA
Emily Ritchie Sr. Exec. of External Affairs NA
Ms. Kylie Bishop B.A., BA (Hons) Psy, MOrgPsych Group Exec. of People, Culture & Sustainability NA

Disclaimer - Data Powered by EOD Historical Data (“EODHD”). All CFDs (stocks, indices, mutual funds, ETFs), and Forex are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. EODHD is not using exchanges data feeds for the pricing data, EODHD is using OTC, peer to peer trades and trading platforms over 100+ sources, EODHD is aggregating its data feeds via VWAP method. Therefore, EOD Historical Data doesn’t bear any responsibility for any trading losses you might incur as a result of using this data. EOD Historical Data or anyone involved with EOD Historical Data will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible. EOD Historical Data does not give any warranties (including, without limitation, as to merchantability or fitness for a particular purpose or use).